These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20819448)

  • 1. Clonal status and clinicopathological features of Langerhans cell histiocytosis.
    Gong L; Zhang WD; Li YH; Liu XY; Yao L; Han XJ; Zhu SJ; Lan M; Zhang W
    J Int Med Res; 2010; 38(3):1099-105. PubMed ID: 20819448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary Langerhans' cell histiocytosis: molecular analysis of clonality.
    Yousem SA; Colby TV; Chen YY; Chen WG; Weiss LM
    Am J Surg Pathol; 2001 May; 25(5):630-6. PubMed ID: 11342775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal proliferation of Langerhans cells in Langerhans cell histiocytosis.
    Yu RC; Chu C; Buluwela L; Chu AC
    Lancet; 1994 Mar; 343(8900):767-8. PubMed ID: 7510816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lesions resembling Langerhans cell histiocytosis in association with other lymphoproliferative disorders: a reactive or neoplastic phenomenon?
    Christie LJ; Evans AT; Bray SE; Smith ME; Kernohan NM; Levison DA; Goodlad JR
    Hum Pathol; 2006 Jan; 37(1):32-9. PubMed ID: 16360413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal status and clinicopathological feature of Erdheim-Chester disease.
    Gong L; He XL; Li YH; Ren KX; Zhang L; Liu XY; Han XJ; Yao L; Zhu SJ; Lan M; Zhang W
    Pathol Res Pract; 2009; 205(9):601-7. PubMed ID: 19339122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of Langerhans cell histiocytosis.
    Badalian-Very G; Vergilio JA; Fleming M; Rollins BJ
    Annu Rev Pathol; 2013 Jan; 8():1-20. PubMed ID: 22906202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Langerhans'-cell histiocytosis (histiocytosis X)--a clonal proliferative disease.
    Willman CL; Busque L; Griffith BB; Favara BE; McClain KL; Duncan MH; Gilliland DG
    N Engl J Med; 1994 Jul; 331(3):154-60. PubMed ID: 8008029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of clonal lymphoid receptor gene rearrangements in langerhans cell histiocytosis.
    Chen W; Wang J; Wang E; Lu Y; Lau SK; Weiss LM; Huang Q
    Am J Surg Pathol; 2010 Jul; 34(7):1049-57. PubMed ID: 20551822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of clonal histiocytes in Langerhans cell histiocytosis: biology and clinical significance.
    Willman CL
    Br J Cancer Suppl; 1994 Sep; 23():S29-33. PubMed ID: 7521201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No genomic aberrations in Langerhans cell histiocytosis as assessed by diverse molecular technologies.
    da Costa CE; Szuhai K; van Eijk R; Hoogeboom M; Sciot R; Mertens F; Björgvinsdóttir H; Debiec-Rychter M; de Krijger RR; Hogendoorn PC; Egeler RM; Annels NE
    Genes Chromosomes Cancer; 2009 Mar; 48(3):239-49. PubMed ID: 19051326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Langerhans' cell histiocytosis (histiocytosis X): immunophenotype and growth fraction.
    Hage C; Willman CL; Favara BE; Isaacson PG
    Hum Pathol; 1993 Aug; 24(8):840-5. PubMed ID: 7690735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1 Is Expressed in Neoplastic Cells of Langerhans Cell Histiocytosis but Not Reactive Langerhans Cell Proliferations.
    Shanmugam V; Craig JW; Hornick JL; Morgan EA; Pinkus GS; Pozdnyakova O
    Am J Surg Pathol; 2017 Oct; 41(10):1390-1396. PubMed ID: 28622183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CyclinD1 Is Useful to Differentiate Langerhans Cell Histiocytosis From Reactive Langerhans Cells.
    Chatterjee D; Vishwajeet V; Saikia UN; Radotra B; De D; Bansal D
    Am J Dermatopathol; 2019 Mar; 41(3):188-192. PubMed ID: 30124506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF1R Is Required for Differentiation and Migration of Langerhans Cells and Langerhans Cell Histiocytosis.
    Lonardi S; Scutera S; Licini S; Lorenzi L; Cesinaro AM; Gatta LB; Castagnoli C; Bollero D; Sparti R; Tomaselli M; Medicina D; Calzetti F; Cassatella MA; Facchetti F; Musso T; Vermi W
    Cancer Immunol Res; 2020 Jun; 8(6):829-841. PubMed ID: 32238382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Langerhans Cell Histiocytosis: A Clinicopathologic Review and Molecular Pathogenetic Update.
    Harmon CM; Brown N
    Arch Pathol Lab Med; 2015 Oct; 139(10):1211-4. PubMed ID: 26414464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale for the application of RANKL inhibition in the treatment of Langerhans cell histiocytosis.
    Makras P; Salagianni M; Revelos K; Anastasilakis AD; Schini M; Tsoli M; Kaltsas G; Andreakos E
    J Clin Endocrinol Metab; 2015 Feb; 100(2):E282-6. PubMed ID: 25375981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Squash smear cytology of Langerhans cell histiocytosis.
    Nahm JH; Yoon G; Do SI; Kim HS
    Int J Clin Exp Pathol; 2015; 8(7):7998-8007. PubMed ID: 26339366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Langerhans cell histiocytosis: a clinicopathologic and immunohistochemical analysis of 258 cases].
    Xu X; Liu WP; Yang QP; Wang WY; Liao DY; Zhao S; Bi CF; Lin L; Min M
    Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):91-6. PubMed ID: 22455884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biology of Langerhans cells and Langerhans cell histiocytosis.
    Bechan GI; Egeler RM; Arceci RJ
    Int Rev Cytol; 2006; 254():1-43. PubMed ID: 17147996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cellular adhesion molecules in Langerhans cell histiocytosis and normal Langerhans cells.
    de Graaf JH; Tamminga RY; Kamps WA; Timens W
    Am J Pathol; 1995 Oct; 147(4):1161-71. PubMed ID: 7573361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.